Therapeutic Areas

Abacus Medicine Pharmaceuticals focuses on specialty and rare-disease
areas where we can make a real difference for patients.

Our current portfolio spans several established rare indications, and we are expanding into broader specialty fields where our European platform and commercialization expertise can accelerate patient access. We partner with Pharma and Biotech innovators developing specialty and rare-disease therapies to bring them to patients across Europe.

Future Focus

We continue to explore additional specialty areas where our European infrastructure and lean partnering model can accelerate access to innovative therapies.

Genetic & Metabolic Disorders

Our commercialisation expertise spans a range of genetic & metabolic disorders and conditions.

Haematology & Oncology

Within haematology, we work with products and therapies serving a handful of key rare diseases.

Cardiovascular Surgery

Our experience also extends to products designed to improve cardiac surgery procedures.
Babak Saadati

We are deeply committed to supporting patients with rare diseases. Every patient matter and we are driven to make a difference where it’s needed most.

Latest articles

Pharma commercialization strategies: A blueprint for launching a new product in Europe

Medical affairs challenges for orphan drugs: the key to a winning KOL engagement strategy

How real-world evidence is changing Health Technology Assessment (HTA) submissions